26 results on '"Santana-Magal, Nadine"'
Search Results
2. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
3. Expression of modified FcγRI enables myeloid cells to elicit robust tumorspecific cytotoxicity.
4. Expression of modified Fc γ RI enables myeloid cells to elicit robust tumor-specific cytotoxicity
5. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
6. A distinct subset of Fc[gamma]RI-expressing Th1 cells exert antibody-mediated cytotoxic activity
7. Data from T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors
8. Supplementary Data from T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors
9. T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors
10. Abstract 4075: A modified FcγRI expressing-T cell, SolidT, enables antibody-mediated cytotoxicity to overcome the limitations of CAR-T cell therapy against solid tumors
11. Data from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
12. Supplemental figure 5 from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
13. Supplemental figure 2 from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
14. Supplemental figure 4 from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
15. Supplemental figure 6 from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
16. Supplemental Figure 1 from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
17. Supplemental figure 3 from Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
18. Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
19. Author response: Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
20. Tumor-reactive T cells are licensed by dendritic cells located in spatially different tissues: implications for dendritic cell vaccines
21. Transient cell-in-cell formation underlies tumor resistance to immunotherapy
22. Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy
23. Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
24. Persistent, circulative transmission of begomoviruses by whitefly vectors
25. Correction: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.
26. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.